In 2020, the company was recognized as a backbone enterprise of the Russian economy. In 2021, “Nanolek” was included in RBC's rating — “50 Fastest Growing Companies in Russia”.
more than 10 innovative drugs have been localized at the plant in the Kirov region in partnership with big pharma companies — world industry leaders.
employees
23% of which are engaged solely in quality control
drugs
in the portfolio. 7 more drugs are under development
billion rubles
have been invested in the company since 2011
billion rubles
taxes paid to in the Kirov region over the past 5 years
Protect people's lives and health by producing the world's best technologies, made available to everyone
From the localization of the drugs of global pharmaceutical companies, to the biotech production of a full cycle and the development of innovative medicines “from scratch”
*GMP (Good Manufacturing Practice) —rules that establish requirements for the organization of production and quality control of drugs for medical and veterinary use.
**ISO 9001 — this standard is based on a number of quality management principles, such as strong customer orientation, management involvement and motivation, process approach and continuous improvement. The application of ISO 9001 helps to ensure that customers consistently receive high-quality products and services.
Attention! You are about to enter a section containing information about prescription drugs. This information is intended only for current medical and pharmaceutical professionals.
Please confirm that you are a current medical or pharmaceutical professional. If you are not a current medical or pharmaceutical professional, please do not proceed.
Are you a current medical or pharmaceutical professional?